Parkinson's Disease Patients Report Significant Symptom Relief After Using New Experimental Soundwave Therapy, Study Finds
A groundbreaking study published today in the journal *Nature Medicine* has revealed that a novel, non-invasive soundwave therapy has led to substantial and sustained motor function improvements in patients with early-stage Parkinson's disease. The research, conducted at a leading neurology institute in London, involved a controlled trial of 120 participants over a six-month period. This therapy, known as focused ultrasound, targets a specific brain region associated with the disorder's characteristic tremors and rigidity. The findings offer a potential new avenue for treatment without the need for surgical implants or drugs, potentially altering long-term disease management. The World Health Organization has indicated a global rise in cases of Parkinson's disease, making the therapy's timeline for regulatory approval a matter of urgent international interest.